[1]
|
Brown, K.W. and Malik, K.T. (2001) The molecular biology of Wilms tumour. Expert Reviews in Molecular Medicine, 2001, 1-16. http://dx.doi.org/10.1017/S1462399401003027
|
[2]
|
Pastore, G., Znaor, A., Spreafico, F., Graf, N., Pritchard-Jones, K. and Steliarova-Foucher, E. (2006) Malignant renal tumours incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. European Journal of Cancer, 42, 2103-2114. http://dx.doi.org/10.1016/j.ejca.2006.05.010
|
[3]
|
Coppes, M.J. and Egeler, R.M. (1999) Genetics of Wilms’ tumor. Seminars in Urologic Oncology, 17, 2-10.
|
[4]
|
Rahman, N., Arbour, L., Houlston, R., Bonaiti-Pellie, C., Abidi, F., Tranchemontagne, J., Ford, D., Narod, S., Pritchard-Jones, K., Foulkes, W.D., Schwartz, C. and Stratton, M.R. (2000) Penetrance of mutations in the familial Wilms tumor gene FWT1. Journal of the National Cancer Institute, 92, 650-652. http://dx.doi.org/10.1093/jnci/92.8.650
|
[5]
|
Menke, A., van der Eb, A.J. and Jochemsen, A.G. (1998) The Wilms’ tumor suppressor WT1: Approaches to gene function. Kidney International, 53, 1512-1518. http://dx.doi.org/10.1046/j.1523-1755.1998.00935.x
|
[6]
|
Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., Jones, C. and Housman, D.E. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell, 60, 509-520. http://dx.doi.org/10.1016/0092-8674(90)90601-A
|
[7]
|
Gessler, M., Konig, A. and Bruns, G.A. (1992) The genomic organization and expression of the WT1 gene. Genomics, 12, 807-813. http://dx.doi.org/10.1016/0888-7543(92)90313-H
|
[8]
|
Madden, S.L., Cook, D.M., Morris, J.F., Gashler, A., Sukhatme, V.P. and Rauscher 3rd, F.J. (1991) Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science, 253, 1550-1553. http://dx.doi.org/10.1126/science.1654597
|
[9]
|
Huff, V. (1998) Wilms tumor genetics. American Journal of Medical Genetics, 79, 260-267. http://dx.doi.org/10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO;2-Q
|
[10]
|
Gessler, M., Konig, A., Arden, K., Grundy, P., Orkin, S., Sallan, S., Peters, C., Ruyle, S., Mandell, J., Li, F., Cavenee, W. and Bruns, G. (1994) Infrequent mutation of the WT1 gene in 77 Wilms’ Tumors. Human Mutation, 3, 212-222. http://dx.doi.org/10.1002/humu.1380030307
|
[11]
|
Segers, H., Kersseboom, R., Alders, M., Pieters, R., Wagner, A. and van den Heuvel-Eibrink, M.M. (2012) Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. European Journal of Cancer, 48, 3249-3256. http://dx.doi.org/10.1016/j.ejca.2012.06.008
|
[12]
|
Little, M., and Wells, C. (1997) A clinical overview of WT1 gene mutations. Human Mutation, 9, 209-225. http://dx.doi.org/10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2
|
[13]
|
Breslow, N.E., Olson, J., Moksness, J., Beckwith, J.B. and Grundy, P. (1996) Familial Wilms’ tumor: A descriptive study. Medical and Pediatric Oncology, 27, 398-403. http://dx.doi.org/10.1002/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H
|
[14]
|
Varanasi, R., Bardeesy, N., Ghahremani, M., Petruzzi, M.J., Nowak, N., Adam, M.A., Grundy, P., Shows, T.B. and Pelletier, J. (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proceedings of the National Academy of Sciences of the United States of America, 91, 3554-3558. http://dx.doi.org/10.1073/pnas.91.9.3554
|
[15]
|
Menke, A.L., van der Eb, A.J. and Jochemsen, A.G. (1998) The Wilms’ tumor 1 gene: Oncogene or tumor suppressor gene? International Review of Cytology, 181, 151-212. http://dx.doi.org/10.1016/S0074-7696(08)60418-0
|
[16]
|
Rauscher 3rd, F.J. (1993) The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB Journal, 7, 896-903.
|
[17]
|
Berger, A.H., Knudson, A.G. and Pandolfi, P.P. (2011) A continuum model for tumour suppression. Nature, 476, 163-169. http://dx.doi.org/10.1038/nature10275
|
[18]
|
Moffett, P., Bruening, W., Nakagama, H., Bardeesy, N., Housman, D., Housman, D.E. and Pelletier, J. (1995) Antagonism of WT1 activity by protein self-association. Proceedings of the National Academy of Sciences of the United States of America, 92, 11105-11109. http://dx.doi.org/10.1073/pnas.92.24.11105
|
[19]
|
Pelletier, J., Bruening, W., Kashtan, C.E., Mauer, S.M., Manivel, J.C., Striegel, J.E., Houghton, D.C., Junien, C., Habib, R., Fouser, L., Fine, R.N., Silverman, B.L., Haber1, D.A. and David Housman, D. (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67, 437-447. http://dx.doi.org/10.1016/0092-8674(91)90194-4
|
[20]
|
Klamt, B., Koziell, A., Poulat, F., Wieacker, P., Scambler, P., Berta, P. and Gessler, M. (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Human Molecular Genetics, 7, 709-714. http://dx.doi.org/10.1093/hmg/7.4.709
|